Non-Insured Health Benefits (NIHB) Newsletter
For our Pharmacy Providers - Spring 2006
Prepared by First Canadian Health
News and Information for Our NIHB Providers
NIHB Toll-Free Inquiry Centre: 1-888-511-4666
News and Views
Welcome to the spring 2006 edition of the Non-Insured Health Benefits
(NIHB) quarterly newsletter. First Canadian Health (FCH) is now
in its eighth year of operations as the claims processor for the
NIHB Program of the First Nations and Inuit Health Branch (FNIHB)
of Health Canada.
Again, FCH would like to thank you for your support as you continue
to provide quality health services to First Nations and Inuit clients
of the NIHB Program.
As always, your comments and questions are welcome. Please contact
the FCH NIHB Toll-Free Inquiry Centre at 1-888-511-4666,
or send your correspondence to:
FCH Provider Relations
3080 Yonge Street, Suite 3002
Toronto, ON M4N 3N1
Up and Coming on the Web
New and easy access to NIHB Provider Information Kits is coming
soon! Starting in the spring of 2006, accessing provider information
on Health Canada's website will be quicker and easier. We are currently
combining the Provider Information Kits and the NIHB Drug Benefit
List (DBL) into one central site that will allow you to view and
print the material in a few simple steps. Visit the new site at
http://www.healthcanada.gc.ca/nihb under 'Health Provider Information'
to find the new kits.
Publishing of the NIHB DBL will continue to occur once a year
and its updating will continue on a quarterly basis. You can access
the most recent electronic version anytime online at http://www.healthcanada.gc.ca/dbl.
NIHB Drug Benefit List (DBL) Update
The spring 2006 DBL updates, which list all changes made to the
NIHB DBL since the last update for winter 2005-2006, will be available
on the NIHB website from April 1, 2006. These updates include the
addition and replacement of Drug Identification Numbers (DIN),
limited use benefits, drugs removed from the Canadian market and
drugs discontinued by the manufacturer effective April 1, 2006.
The most recent electronic version of the NIHB DBL reflects these
updates. Please refer to the website at the following URL address:
www.hc-sc.gc.ca/fnih-spni/pubs/nihb-ssna_e.html
Add your pharmacy to the distribution list for a hardcopy of the
April 1, 2006 reprint of the NIHB DBL by submitting a request using
the following form:
Please complete the fields in the shaded box below, and fax this
page to (613)-941-6249 no later than June 1, 2006. FNIHB will not
provide hardcopies of the April 2006 DBL reprint after June 1,
2006.
Yes! Please send a hardcopy of the April 1, 2006 DBL update
to our office....
Name:
Provider Number:
Address:
City:
Province:
Postal Code:
Telephone:
Email:
Should you have any questions, please contact the FCH NIHB Toll-Free
Inquiry Centre at 1-888-511-4666.
Changes to the Electronic Claims Submission Network
Emergis Inc. completed an upgrade of its electronic claims submission
network in February 2006. As a result, it is necessary that all
Canadian claims processing software be reconfigured in order to
permit claims submission to insurers, third party payers, and claim
adjudicators via the improved network.
If your office has received a "Host Unavailable" or "Host
Time Out" message while attempting to submit claims electronically,
FCH recommends that you contact your software vendor for assistance
in completing the necessary upgrades. If you require further information,
please contact the FCH NIHB Toll Free Inquiry Centre at 1-888-511-4666.
Billing of Extemporaneous Mixtures
Findings by NIHB's Provider Audit indicate that claims submitted
under the pseudo-DIN for extemporaneous mixtures are often inappropriate.
Please note that the NIHB program defines extemporaneous mixtures
as:
".products that require compounding
in a pharmacy in accordance with the orders of a prescriber and
which must not duplicate the formulation of commercially manufactured
drug products."
An example of inappropriate billing of extemporaneous mixtures
is as follows; A prescription indicates "25mg of Hydrochlorothiazide
(HCTZ) - take ½ tablet daily,"the pharmacy splits the
pills in half and submits the claim as an extemporaneous mixture.
If the pharmacy splits the pills on behalf of the client, this
claim must be submitted using the HCTZ 25mg DIN and not as an extemporaneous
mixture. According to the aforementioned definition of extemporaneous
mixtures, the claimed item duplicates the formulation of a commercially
manufactured drug product and would be recovered in the audit process
were it submitted under the pseudo-DIN for extemporaneous mixtures.
As a reminder, claims submitted for extemporaneous mixtures containing
exceptions, limited use benefits, or for commercially manufactured
drugs without a prior approval number, will be subject to reversal.
The NIHB Pharmacy/Medical Supplies and Equipment Provider Information
Kit, First Canadian Health/NIHB Program Newsletters, and NIHB Program
Drug Bulletins all detail the NIHB Program's billing requirements.
These documents are available on the NIHB Web site at: www.hc-sc.gc.ca/fnih-spni/pubs/nihb-ssna_e.html.
Prior Approval for Diclofenac
The NIHB program reviewed a submission request for diclofenac
topical preparation and concluded that the evidence base for the
utilization of diclofenac in a topical form was not sufficient
to recommend the addition of this product to the NIHB Drug Benefit
List. Therefore, a pharmacist receiving a prescription to dispense
a topical preparation containing diclofenac must obtain prior approval
from the National Drug Exception Centre before dispensing the preparation.
This applies even when diclofenac oral tablets are the primary
ingredient in the compound.
It is important to remember that a pharmacist will not receive
payment for any compounds that replicate a drug product already
available on the market. Please note that all claims submitted
to the NIHB program are subject to audit.
Discrepancies in quantity and Days Supply (Seven-Day Blister
Packs)
Audit findings have identified situations where the quantity/days
supply recorded on claims for Seven-Day Blister Packs is contradictory
to the quantity indicated on the package. The days supply for a
Seven-Day Blister Pack must always be seven with any applicable
refill billing processed only after two-thirds (2/3) of the previous
fill.
Accurate reporting of the days supply is essential for the adjudication
and verification of claims. Providers must indicate the number
of days treatment contained in the prescription.
Submitting Claims for AeroChamber ® Valved Holding Chambers
(VHCs)
Please submit the correct item code or pseudo-DIN when submitting
claims for AeroChamber ® VHCs. For example, when dispensing
an adult-size AeroChamber ® to an adult, the item code or pseudo
DIN submitted for payment must be for an adult-size AeroChamber ®.
Recent audits have uncovered numerous instances where payment
was claimed using the incorrect pseudo-DIN. Please ensure that
all claims submitted for spacer devices use the correct pseudo-DIN.
The current version of the NIHB Pharmacy/Medical Supplies and
Equipment Provider Information Kit is always available on the NIHB
website at:
www.hc-sc.gc.ca/fnih-spni/pubs/index_e.html
Providers without internet access can contact the FCH NIHB Toll-Free
Inquiry Centre at 1-888-511-4666.
|